Potential of adiponectin as a cardioprotective agent.

Item

http://www.wikidata.org/entity/Q37608586

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Potential of adiponectin as a cardioprotective agent.

@en

Potential of adiponectin as a cardioprotective agent.

@nl

type

Item

label

Potential of adiponectin as a cardioprotective agent.

@en

Potential of adiponectin as a cardioprotective agent.

@nl

prefLabel

Potential of adiponectin as a cardioprotective agent.

@en

Potential of adiponectin as a cardioprotective agent.

@nl

P1476

Potential of adiponectin as a cardioprotective agent.

@en

P2093

Kenneth Walsh

http://www.w3.org/2001/XMLSchema#string

Noriyuki Ouchi

http://www.w3.org/2001/XMLSchema#string

Rei Shibata

http://www.w3.org/2001/XMLSchema#string

Toyoaki Murohara

http://www.w3.org/2001/XMLSchema#string

P2860

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes

T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin

Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning

Adiponectin and future coronary heart disease events among men with type 2 diabetes

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

P304

647-656

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14796678.3.6.647

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19804285

http://www.w3.org/2001/XMLSchema#string